Wooton, Richel M.
HRN: 24-01-00 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/28/2023
CEFUROXIME 1.5GM (VIAL)
10/28/2023
10/28/2023
IV
1.5 G
Prior To OR
For Repeat Cs G7P6 (6006)
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes